Ultromics logo
Startup

Ultromics

See Ultromics's full profile

BOOK A DEMO
Headquarters

United Kingdom

Founded Year

2017

Total Funding

$58.8M

Employees

51 - 200

Status

Active


About Ultromics

Ultromics is a global health technology company which provides autonomous echocardiography analysis through innovative AI solutions empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease.

Headquarters

Oxford, United Kingdom


General Information on Ultromics

Brand name Ultromics
Company name Ultromics Ltd.
Website https://www.ultromics.com/
Founded year 2017
Employees 51 - 200
Founding team

Paul Leeson

Ross Upton

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Ultromics

Plato Data Intelligence, Plato Vertical Search 08.12.2022
Ultromics yana karɓar izini daga FDA don dandamali na tushen AI don gano HFpEF

Ultromics ya sami izini daga Hukumar Abinci da Magunguna ta Amurka (FDA) don dandamalin fasahar sa na wucin gadi (AI), EchoGo Heart Failure, wanda ke ba da damar gano gazawar zuciya tare da juzu'in fitarwa (HFpEF) daidai. Echocardiography da AI ƙwararru daga Ultromics, wanda ya fito daga Jami'ar Oxford a Burtaniya, ya haɓaka na'urar tare da haɗin gwiwar Mayo Clinic. Yin amfani da AI, na'urar gazawar zuciya ta EchoGo na iya gano daidai HFpEF, ...

Ultromics news
Plato Data Intelligence, Plato Vertical Search 08.12.2022
Ultromics receives clearance from FDA for AI-based platform to detect HFpEF

Zephyrnet Ultromics receives clearance from FDA for AI-based platform to detect HFpEF Republished By Plato December 7, 2022 Views: The EchoGo Heart Failure device can precisely detect HFpEF from a single echocardiogram image. Credit: Ultromics / PRNewswire. Ultromics has received clearance from the US Food and Drug Administration (FDA) for its artificial intelligence (AI)-based platform, EchoGo Heart Failure, which enables ...

Ultromics news
Plato Data Intelligence, Plato Vertical Search 08.12.2022
Ultromics gba idasilẹ lati FDA fun ipilẹ-orisun AI lati ṣawari HFpEF

ọjọ:

Ultromics news
Plato Data Intelligence, Plato Vertical Search 08.12.2022
Ultromics får tillstånd från FDA för AI-baserad plattform för att detektera HFpEF

Ultromics news
FDAnews Device Daily Bulletin 08.12.2022
Ultromics’ EchoGo Heart Failure IA Diagnosis Device Cleared

The FDA has granted clearance to Ultromics’ EchoGo Heart Failure device which uses artificial intelligence to diagnose heart failure with preserved ejection fraction (HFpEF) from a single echocardiogram image. HFpEF is the most common form of heart failure and accounts for 50 percent of cases, increasing at about 1 percent annually because of an aging population with comorbidities of high blood pressure, diabetes and obesity. The device has ...

Aunt Minnie 30.09.2022
Ultromics joins initiative researching heart failure syndrome

The initiative also includes the U.S. National Institutes of Health and the National Heart Lung and Blood Institute, managed by the Foundation for the National Institutes of Health. The five-year, $37 million collaboration aims to investigate the syndrome of heart failure with preserved ejection fraction (HFpEF). Ultromics' artificial intelligence tools will be utilized in the research. The company's HFpEF diagnostic algorithm was recently ...

Ultromics news
StreetInsider 30.09.2022
Ultromics joins FNIH Partnership to Transform Heart Failure Detection

The FNIH's Accelerating Medicines Partnership® Heart Failure OXFORD, England Sept. 29, 2022 /PRNewswire/ -- , a digital health technology company pioneering the development of transformative heart failure diagnostics, has joined as a full partner including the (NIH) and the (NHLBI), managed by the (FNIH). The 5-year, $37 million multi-stakeholder collaboration brings together partners from the public and private sectors across the world to ...

Ultromics news
Med-Tech Innovation 11.11.2021
Caption Health and Ultromics partnership to improve ultrasound

Together, the companies will jointly offer the Caption AI software platform alongside Ultromics’ EchoGo deep ultrasound analytics – allowing more providers the ability to perform ultrasounds and automatically calculate key indicators of heart function, which drive earlier and more accurate disease diagnosis.Access to proper cardiac health care is a global problem, leading to countless preventable deaths. A limited number of specialists are ...

Ultromics news
Cardiac Rhythm News 11.11.2021
Caption Health and Ultromics partner to increase availability of heart disease detection and management tools

Access to effective cardiac health care is a global issue, leading to countless preventable deaths. A limited number of specialists are available to perform and analyse cardiac ultrasounds – a key diagnostic procedure for identifying the beginning or progression of heart failure, valve disease, and coronary artery disease. According to a recent study , 46% of patients in the United States (US) diagnosed with heart failure in acute care settings ...